Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal.

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:

Tuesday, October 23, 2018

Korean Red Ginseng enhances neurogenesis in the subventricular zone of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated mice

Yes this is in mice and for Parkinsons but WHOM do we go to to get this tested in humans with stroke? 

Korean Red Ginseng enhances neurogenesis in the subventricular zone of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated mice

 Sun Ryu1, Hyongjun Jeon2,  Sungtae Koo2 and  Seungtae Kim2*
  • 1Korean Medicine Research Center for Healthy Aging, Pusan National University, South Korea
  • 2Department of Korean Medical Science, Pusan National University, South Korea
Modulation of endogenous neurogenesis would have a significant impact on future therapeutic strategies for neurodegenerative diseases. Recent studies have suggested that the enhancement of adult neurogenesis can be helpful in the treatment of Parkinson’s disease (PD). In this study, we investigated augmentative effects of Korean Red Ginseng (KRG) on neurogenesis in the subventricular zone (SVZ) of a PD mouse model. Male eight-week-old C57BL/6 mice were injected with vehicle or 20 mg/kg of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) four times at 2-h intervals. After the final injection, they were administrated vehicle or 100 mg/kg of Korean Red Ginseng extract and injected intraperitoneally with 50 mg/kg of 5’-bromo-2’-deoxyuridine-monophosphate (BrdU) once a day for 14 consecutive days. After the last pole test, dopaminergic neuronal survival in the nigrostriatal pathway, cell proliferation in the SVZ and mRNA expressions of neurotrophic factors and dopamine receptors in the striatum were evaluated. KRG administration suppressed MPTP-induced dopaminergic neuronal death in the nigrostriatal pathway, increased the number of BrdU- and BrdU/doublecortin-positive cells in the SVZ and enhanced the expressions of proliferation cell nuclear antigen, brain derived neurotrophic factor, glial cell derived neurotrophic factor, cerebral dopamine neurotrophic factor, ciliary neurotrophic factor, dopamine receptor D3 and D5 mRNAs. These results suggest that KRG administration augments neurogenesis in the SVZ of a PD mouse model.
Keywords: Parkinson's disease (PD), Korean red ginseng (KRG), Neurogenesis, MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), subventricular zone (SVZ)
Received: 29 Jun 2018; Accepted: 18 Oct 2018.
Edited by:
Seung-Nam Kim, Dongguk University Seoul, South Korea
Reviewed by:
Songhee Jeon, Chonnam National University Medical School, South Korea
Ji-Yeun Park, Daejeon University, South Korea  
Copyright: © 2018 Ryu, Jeon, Koo and Kim. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

No comments:

Post a Comment